| The 2021 WHO classification of lung tumors: impact of advances since 2015 AG Nicholson, MS Tsao, MB Beasley, AC Borczuk, E Brambilla, ... Journal of Thoracic Oncology 17 (3), 362-387, 2022 | 814 | 2022 |
| Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study N Van Zandwijk, N Pavlakis, SC Kao, A Linton, MJ Boyer, S Clarke, ... The Lancet Oncology 18 (10), 1386-1396, 2017 | 611 | 2017 |
| Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non–small cell lung carcinoma: a systematic … CK Lee, J Man, S Lord, W Cooper, M Links, V Gebski, RS Herbst, ... JAMA oncology 4 (2), 210-216, 2018 | 523 | 2018 |
| The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer RM Bremnes, LT Busund, TL Kilvær, S Andersen, E Richardsen, ... Journal of Thoracic Oncology 11 (6), 789-800, 2016 | 469 | 2016 |
| Molecular biology of lung cancer WA Cooper, DCL Lam, SA O’Toole, JD Minna Journal of thoracic disease 5 (Suppl 5), S479, 2013 | 468 | 2013 |
| A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee AL Moreira, PSS Ocampo, Y Xia, H Zhong, PA Russell, Y Minami, ... Journal of Thoracic Oncology 15 (10), 1599-1610, 2020 | 338 | 2020 |
| PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma WA Cooper, T Tran, RE Vilain, J Madore, CI Selinger, M Kohonen-Corish, ... Lung cancer 89 (2), 181-188, 2015 | 324 | 2015 |
| Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study LK Troy, C Grainge, TJ Corte, JP Williamson, MP Vallely, WA Cooper, ... The lancet Respiratory medicine 8 (2), 171-181, 2020 | 310 | 2020 |
| IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy WD Travis, S Dacic, I Wistuba, L Sholl, P Adusumilli, L Bubendorf, P Bunn, ... Journal of Thoracic Oncology 15 (5), 709-740, 2020 | 304 | 2020 |
| PD-L1 testing for lung cancer in 2019: perspective from the IASLC pathology committee S Lantuejoul, M Sound-Tsao, WA Cooper, N Girard, FR Hirsch, AC Roden, ... Journal of Thoracic Oncology 15 (4), 499-519, 2020 | 264 | 2020 |
| Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry HE Jo, I Glaspole, C Grainge, N Goh, PMA Hopkins, Y Moodley, ... European Respiratory Journal 49 (2), 2017 | 228 | 2017 |
| The promises and challenges of tumor mutation burden as an immunotherapy biomarker: a perspective from the International Association for the Study of Lung Cancer Pathology … LM Sholl, FR Hirsch, D Hwang, J Botling, F Lopez-Rios, L Bubendorf, ... Journal of Thoracic Oncology 15 (9), 1409-1424, 2020 | 216 | 2020 |
| Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation EC Paver, WA Cooper, AJ Colebatch, PM Ferguson, SK Hill, T Lum, ... Pathology 53 (2), 141-156, 2021 | 192 | 2021 |
| Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization CI Selinger, TM Rogers, PA Russell, S O'toole, PY Yip, GM Wright, ... Modern pathology 26 (12), 1545-1553, 2013 | 171 | 2013 |
| Comparison of four PD-L1 immunohistochemical assays in lung cancer S Hendry, DJ Byrne, GM Wright, RJ Young, S Sturrock, WA Cooper, ... Journal of Thoracic Oncology 13 (3), 367-376, 2018 | 159 | 2018 |
| Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma SC Kao, YY Cheng, M Williams, MB Kirschner, J Madore, T Lum, ... Journal of Thoracic Oncology 12 (9), 1421-1433, 2017 | 144 | 2017 |
| The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential diagnosis. An international reproducibility study in a demanding set of cases E Thunnissen, AC Borczuk, DB Flieder, B Witte, MB Beasley, JH Chung, ... Journal of thoracic oncology 12 (2), 334-346, 2017 | 142 | 2017 |
| Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma MS Carlino, LE Haydu, H Kakavand, AM Menzies, AL Hamilton, B Yu, ... British journal of cancer 111 (2), 292-299, 2014 | 129 | 2014 |
| Intra-and interobserver reproducibility assessment of PD-L1 biomarker in non–small cell lung cancer WA Cooper, PA Russell, M Cherian, EE Duhig, D Godbolt, PJ Jessup, ... Clinical Cancer Research 23 (16), 4569-4577, 2017 | 126 | 2017 |
| Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the A ustralian IPF R egistry IN Glaspole, SA Chapman, WA Cooper, SJ Ellis, NS Goh, PM Hopkins, ... Respirology 22 (5), 950-956, 2017 | 125 | 2017 |
